Stay updated on Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial page.

Latest updates to the Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedThe page displays the ClinicalTrials.gov record for this breast cancer study, including its eligibility criteria, treatment arms, outcome measures, locations, and study documents, instead of an access-denied screen.SummaryDifference64%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer shows an updated site revision, from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The site revision number changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the expected study details and rendering the page inaccessible to viewers seeking information about this trial.SummaryDifference19%

- Check62 days agoChange DetectedThe page now displays Revision: v3.7.0, reflecting a software release version. This update changes only the version label and does not modify the study data or visible content.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab and Entinostat in aTN Breast Cancer Clinical Trial page.